Logo image of VBLT

VASCULAR BIOGENICS LTD (VBLT) Stock News

NASDAQ:VBLT - Nasdaq - IL0011327454 - Common Stock - Currency: USD

0.156  -0.02 (-8.77%)

After market: 0.168 +0.01 (+7.69%)

VBLT Latest News, Press Relases and Analysis

News Image
2 years ago - VBL Therapeutics

VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting

Approved Merger with Notable Labs and All Other Proposals Merger Expected to Close and Begin Trading as Combined Company Under the NTBL Ticker on Nasdaq...

News Image
2 years ago - Benzinga

Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday.

Mentions: SONX RVLP MSS PEV ...

News Image
2 years ago - Benzinga

Why Avidity Biosciences Shares Are Trading Higher By Around 9%: 20 Stocks Moving Premarket

Gainers Maris-Tech Ltd. (NASDAQ: MTEK) shares rose 38% to $1.38 in pre-market trading, after gaining 6% on Friday. Maris-Tech, on Friday, disclosed the launch of Jupiter Drones, an innovative, drone-oriented solution based on Maris-Tech's Jupiter Nano platform.

Mentions: TMPO MKUL PRZO XRTX ...

News Image
2 years ago - VBL Therapeutics

VBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meeting

Shareholders of record as of September 5, 2023 are eligible to vote at the VBL Shareholder Meeting on October 12, 2023...

News Image
2 years ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers that traders will want to watch on Thursday!

Mentions: SGBX NIR SCLX MURF ...

News Image
2 years ago - VBL Therapeutics

VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC

Merger with Notable expected to close in mid-October, subject to shareholder approval Special shareholder meeting scheduled for October 12, 2023 MODI’IN,...

News Image
2 years ago - VBL Therapeutics

VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Merger with Notable expected to close in late September or October, subject to VBL’s S-4 registration statement being declared effective and shareholder...

News Image
2 years ago - VBL Therapeutics

VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

Recently filed S-4 registration statement for proposed merger with Notable; expects to close the transaction in Q3 2023, subject to SEC review and...

News Image
2 years ago - VBL Therapeutics

VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update

MODIIN, Israel and NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (VBL), today announced financial results for the fiscal...

News Image
2 years ago - Seeking Alpha

Vascular Biogenics stock dips amid sale of manufacturing facility to Aleph Farms

Aleph Farms said it has acquired a manufacturing facility in Modi'in, Israel, and certain related assets from VBL Therapeutics (VBLT).Last week, Israel-based Vascular Biogenics...

News Image
2 years ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on!

Mentions: CING BAER AVGR LUNR ...

News Image
2 years ago - InvestorPlace

Why Are Chip Stocks Up Today?

Chip stocks are on the rise Thursday and we've got all the details investors need to know about the sector's gains today!

Mentions: NVDA AMD INTC TSM ...

News Image
2 years ago - InvestorPlace

Why Is Vascular Biogenics (VBLT) Stock Up 52%?

Vascular Biogenics (VBLT) stock is rocketing higher on Thursday following news of a merger with Notable Labs and a ticker change.

Mentions: WBA TDOC GE

News Image
2 years ago - Seeking Alpha

VBLT stock rises on all-stock merger deal with Notable Labs (NASDAQ:VBLT)

Israeli biotech Vascular Biogenics (VBLT), known as VBL Therapeutics, added ~85% after the company and U.S.-based Notable Labs announced an all-stock merger deal. Read the full story here.

News Image
2 years ago - VBL Therapeutics

VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement

Merger will create Nasdaq-listed, clinical-stage therapeutic platform company developing new precision medicines for patient populations selected through...

News Image
2 years ago - VBL Therapeutics

VBL Therapeutics Announces Agreement to Sell Manufacturing Facility and Certain Related Assets for $7.1 Million in Cash

MODIIN, Israel and NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a biotechnology company developing targeted medicines for...

News Image
2 years ago - VBL Therapeutics

VBL Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Continued progress on previously announced strategic process to maximize shareholder value...